![Matthew Gombrich](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Matthew Gombrich
Directeur Technique/Scientifique/R&D chez Vivione Biosciences LLC
Profil
Matthew Gombrich is currently the Chief Medical Officer at Vivione Biosciences LLC since 2014.
He previously worked as the Chief Medical Officer at Vivione Biosciences, Inc. from 2014 to 2015.
Dr. Gombrich received his undergraduate and graduate degrees from Case Western Reserve University in 2005.
Postes actifs de Matthew Gombrich
Sociétés | Poste | Début |
---|---|---|
Vivione Biosciences LLC
![]() Vivione Biosciences LLC BiotechnologyHealth Technology Vivione Biosciences, formerly LITMUS RAPID-B, is powered by RAPID-B technology, an integrated system of Hardware, Software and Wetware that tests bacteria in key environments. Their mission is to revolutionize the Clinical and Medical Fields, Food and Industrial Safety, Water Safety and Bio-Defense by utilizing one compact, universal platform for all diagnostic testing that can be used for bacteria, viruses and toxins. Taking the place of outdated culture-based, immunology-based and molecular-based methods that take countless hours and many times, days, RAPID-B provides more accurate results for each of these fields in minutes to a few hours. Their technology has combined flow cytometry with their own proprietary reagents to achieve a single cell detection capability in minutes. Unlike culture-based methods, the RAPID-B system does not require isolation of bacteria. It works with the background interference from complex Matrices like food. | Directeur Technique/Scientifique/R&D | 29/01/2014 |
Anciens postes connus de Matthew Gombrich
Sociétés | Poste | Fin |
---|---|---|
VIVIONE BIOSCIENCES INC | Directeur Technique/Scientifique/R&D | 01/10/2015 |
Formation de Matthew Gombrich
Case Western Reserve University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
VIVIONE BIOSCIENCES INC | Finance |
Entreprise privées | 1 |
---|---|
Vivione Biosciences LLC
![]() Vivione Biosciences LLC BiotechnologyHealth Technology Vivione Biosciences, formerly LITMUS RAPID-B, is powered by RAPID-B technology, an integrated system of Hardware, Software and Wetware that tests bacteria in key environments. Their mission is to revolutionize the Clinical and Medical Fields, Food and Industrial Safety, Water Safety and Bio-Defense by utilizing one compact, universal platform for all diagnostic testing that can be used for bacteria, viruses and toxins. Taking the place of outdated culture-based, immunology-based and molecular-based methods that take countless hours and many times, days, RAPID-B provides more accurate results for each of these fields in minutes to a few hours. Their technology has combined flow cytometry with their own proprietary reagents to achieve a single cell detection capability in minutes. Unlike culture-based methods, the RAPID-B system does not require isolation of bacteria. It works with the background interference from complex Matrices like food. | Health Technology |